2021
Proteomic Profiles in Patients with Thrombosis Due to COVID-19 Are Distinct from Non-COVID-19 Thrombosis
Madeeva D, Borges K, Shallow M, Juthani P, Wang S, Gupta A, Chun H, Lee A, Pine A. Proteomic Profiles in Patients with Thrombosis Due to COVID-19 Are Distinct from Non-COVID-19 Thrombosis. Blood 2021, 138: 777. PMCID: PMC8701622, DOI: 10.1182/blood-2021-153959.Peer-Reviewed Original ResearchSerum amyloid ACOVID-19 patientsVenous thromboembolismCOVID-19 infectionLipocalin-2Thromboembolic eventsThromboembolic complicationsPentraxin 3Complement factors C2COVID-19Lower extremity Doppler ultrasoundTissue factorComplement activationCell adhesion molecule-1Pathogenesis of thromboembolismInstitutional review board approvalChest CT angiographyAdhesion molecule-1Endothelial cell adhesion molecule-1Novel therapeutic strategiesSodium citrate tubesReview board approvalClassical complement pathwayRadiologic confirmationICU patients
2011
Diagnosis and Management of Life-Threatening Pulmonary Embolism
Marshall PS, Mathews KS, Siegel MD. Diagnosis and Management of Life-Threatening Pulmonary Embolism. Journal Of Intensive Care Medicine 2011, 26: 275-294. PMID: 21606060, DOI: 10.1177/0885066610392658.Peer-Reviewed Original ResearchConceptsMassive pulmonary embolusDiagnosis of PECatheter-based therapiesPulmonary emboliTomographic pulmonary angiographySurgical embolectomyThrombolytic therapyPoor outcomePulmonary angiographyLife-threatening pulmonary emboliLife-Threatening Pulmonary EmbolismLower extremity Doppler ultrasoundInferior vena cava filterComplicated hospital courseImproved pulmonary perfusionPulmonary artery vasodilatorsRecurrent pulmonary emboliRight ventricular dysfunctionUse of vasopressorsBrain natriuretic peptidePresence of hypotensionLife-threatening hemorrhageChoice of treatmentCatheter-based interventionsVena cava filters
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply